Promis Neurosciences Inc. (PMN) — 8-K Filings

8-K Filings (26)

• ProMIS Neurosciences Files 8-K on Financial Results — Mar 25, 2026
  ProMIS Neurosciences Inc. filed an 8-K on March 25, 2026, reporting its results of operations and financial condition under Item 2.02. This filing, with accessi
• ProMIS Neurosciences Inc. Files 8-K — Dec 16, 2025 Risk: low
  On December 12, 2025, ProMIS Neurosciences Inc. filed an 8-K report. The filing indicates that the company's principal executive offices are located at Suite 20
• ProMIS Neurosciences Files 8-K — Nov 24, 2025 Risk: low
  ProMIS Neurosciences Inc. filed an 8-K on November 24, 2025, reporting amendments to its articles of incorporation or bylaws, other events, and financial statem
• ProMIS Neurosciences Files 8-K on Shareholder Vote Matters — Nov 19, 2025 Risk: medium
  ProMIS Neurosciences Inc. filed an 8-K on November 17, 2025, reporting on a submission of matters to a vote of security holders. The company, formerly known as
• ProMIS Neurosciences Announces Board and Officer Changes — Oct 24, 2025 Risk: medium
  ProMIS Neurosciences Inc. announced on October 22, 2025, a change in its board of directors, including the election of new directors and the appointment of cert
• ProMIS Neurosciences Announces Board and Executive Changes — Sep 30, 2025 Risk: medium
  ProMIS Neurosciences Inc. announced on September 26, 2025, a change in its board of directors and executive compensation arrangements. The filing details the de
• ProMIS Neurosciences Files 8-K — Sep 3, 2025 Risk: low
  ProMIS Neurosciences Inc. filed an 8-K on September 3, 2025, reporting on various events. The filing includes information related to financial statements and ex
• ProMIS Neurosciences Enters Material Definitive Agreement — Aug 19, 2025 Risk: medium
  ProMIS Neurosciences Inc. entered into a material definitive agreement on August 13, 2025. The company, formerly known as Amorfix Life Sciences Ltd., is incorpo
• ProMIS Neurosciences Files 8-K: Material Agreement & Equity Sales — Jul 28, 2025 Risk: medium
  ProMIS Neurosciences Inc. announced on July 28, 2025, that it entered into a material definitive agreement. The company also reported on unregistered sales of e
• ProMIS Neurosciences Enters Material Definitive Agreement — Jul 22, 2025 Risk: medium
  On July 21, 2025, ProMIS Neurosciences Inc. entered into a material definitive agreement. The company, formerly known as AMORFIX LIFE SCIENCES LTD, is incorpora
• Sun Pharma to Acquire ProMIS Neurosciences for $117M — Jul 7, 2025 Risk: medium
  ProMIS Neurosciences Inc. announced on July 3, 2025, that it has entered into a definitive agreement to be acquired by a subsidiary of Sun Pharmaceutical Indust
• ProMIS Neurosciences Files 8-K on Board Changes and Votes — Jun 13, 2025 Risk: medium
  ProMIS Neurosciences Inc. filed an 8-K on June 13, 2025, reporting on events from June 12, 2025. The filing covers the departure and election of directors, appo
• ProMIS Neurosciences Files 8-K — Feb 25, 2025 Risk: low
  ProMIS Neurosciences Inc. filed an 8-K on February 25, 2025, reporting under Regulation FD and including financial statements and exhibits. The company, formerl
• ProMIS Neurosciences Announces Board and Executive Changes — Feb 19, 2025 Risk: medium
  ProMIS Neurosciences Inc. announced on February 14, 2025, changes in its board of directors and executive compensation arrangements. The filing details the depa
• ProMIS Neurosciences Files 8-K — Jan 27, 2025 Risk: low
  ProMIS Neurosciences Inc. filed an 8-K on January 27, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly kn
• ProMIS Neurosciences Files 8-K — Jan 10, 2025 Risk: low
  ProMIS Neurosciences Inc. filed an 8-K on January 10, 2025, reporting on various events. The filing includes information related to Regulation FD disclosures, o
• ProMIS Neurosciences Faces Delisting Concerns — Jan 8, 2025 Risk: high
  ProMIS Neurosciences Inc. filed an 8-K on January 8, 2025, to report a notice of delisting or failure to meet continued listing standards. The company, formerly
• ProMIS Neurosciences Files 8-K on Shareholder Vote Matters — Oct 24, 2024 Risk: low
  ProMIS Neurosciences Inc. filed an 8-K on October 24, 2024, reporting on matters submitted to a vote of security holders as of October 23, 2024. The filing deta
• ProMIS Neurosciences Announces Board and Officer Changes — Oct 10, 2024 Risk: medium
  ProMIS Neurosciences Inc. announced on October 8, 2024, changes in its board of directors and executive officers. The filing details the election of new directo
• ProMIS Neurosciences Completes Merger with HealthBank Global — Jul 29, 2024 Risk: medium
  On July 22, 2024, ProMIS Neurosciences Inc. announced the closing of its previously disclosed business combination with HealthBank Global Holdings Inc. The comb
• ProMIS Neurosciences Files 8-K Report — Jul 26, 2024 Risk: low
  On July 26, 2024, ProMIS Neurosciences Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a
• ProMIS Neurosciences Faces Nasdaq Delisting Warning — Jul 5, 2024 Risk: high
  ProMIS Neurosciences Inc. announced on July 2, 2024, that it received a notice from the Nasdaq Stock Market indicating non-compliance with listing rules. The co
• ProMIS Neurosciences Holds Shareholder Meeting — Jun 14, 2024 Risk: low
  On June 13, 2024, ProMIS Neurosciences Inc. filed an 8-K report to announce the results of its annual and special meeting of shareholders. The company's shareho
• ProMIS Neurosciences Files 8-K Report — Apr 30, 2024 Risk: low
  On April 30, 2024, ProMIS Neurosciences Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with a Regulation FD di
• ProMIS Neurosciences Enters Material Definitive Agreement — Jan 5, 2024
  ProMIS Neurosciences Inc. filed an 8-K on January 5, 2024, to report an "Entry into a Material Definitive Agreement." This filing indicates a significant new co
• ProMIS Neurosciences Files 8-K on Corporate Governance, Compensation — Jan 3, 2024
  ProMIS Neurosciences Inc. filed an 8-K on January 3, 2024, reporting events that occurred on December 30, 2023. This filing primarily covers routine corporate g

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX